These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Symptomatic hyperlactataemia and lactic acidosis in the era of highly active antiretroviral therapy. Eshun-Wilson I; Soentjens P; Zeier M; Taljaard J S Afr Med J; 2005 Dec; 95(12):929-30. PubMed ID: 16465351 [No Abstract] [Full Text] [Related]
8. Evidence for mitochondrial toxicity: lactic acidosis as proof of concept. Brinkman K J HIV Ther; 2001 Mar; 6(1):13-6. PubMed ID: 11501196 [No Abstract] [Full Text] [Related]
9. Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects. Bongiovanni M; Fausto A; Cicconi P; Aliprandi A; Cornalba G; Bini T; Sardanelli F; D'Arminio Monforte A J Antimicrob Chemother; 2006 Aug; 58(2):485-6. PubMed ID: 16751202 [No Abstract] [Full Text] [Related]
10. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment. Vrouenraets SM; Treskes M; Regez RM; Troost N; Smulders YM; Weigel HM; Frissen PH; Brinkman K Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477 [TBL] [Abstract][Full Text] [Related]
11. Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine. Claessens YE; Cariou A; Monchi M; Soufir L; Azoulay E; Rouges P; Goldgran-Toledano D; Branche F; Dhainaut JF Crit Care Med; 2003 Apr; 31(4):1042-7. PubMed ID: 12682470 [TBL] [Abstract][Full Text] [Related]
13. Symptomatic hyperlactatemia in a patient on nucleoside reverse transcriptase inhibitors. Ball SC AIDS Read; 2001 Dec; 11(12):593-5. PubMed ID: 11806170 [No Abstract] [Full Text] [Related]
14. Human immunodeficiency virus infection with human granulocytic ehrlichiosis complicated by symptomatic lactic acidosis. Springer SA; Altice FL Clin Infect Dis; 2003 Jun; 36(12):e162-4. PubMed ID: 12802782 [TBL] [Abstract][Full Text] [Related]
15. Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy. Patel V; Hedayati SS Nat Clin Pract Nephrol; 2006 Feb; 2(2):109-14; quiz 115. PubMed ID: 16932402 [TBL] [Abstract][Full Text] [Related]
16. Hyperlactatemia and lactic acidosis: should routine screening be considered? Moyle G AIDS Read; 2002 Aug; 12(8):344-8. PubMed ID: 12229891 [No Abstract] [Full Text] [Related]
17. Highly active antiretroviral therapy (HAART)-associated lactic acidosis: in vitro effects of combination of nucleoside analogues and protease inhibitors on mitochondrial function and lactic acid production. Nerurkar PV; Pearson L; Frank JE; Yanagihara R; Nerurkar VR Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1205-11. PubMed ID: 14983988 [TBL] [Abstract][Full Text] [Related]
18. Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy. Nelson M; Azwa A; Sokwala A; Harania RS; Stebbing J AIDS; 2008 Jul; 22(11):1374-6. PubMed ID: 18580619 [TBL] [Abstract][Full Text] [Related]
19. Clinical manifestations of mitochondrial toxicity. Walker UA J HIV Ther; 2001 Mar; 6(1):17-21. PubMed ID: 11501197 [No Abstract] [Full Text] [Related]